Fennec Pharmaceuticals Inc.FENCNASDAQ
Loading
Revenue ContractionContracting
Percentile Rank93
3Y CAGR+197.4%
5Y CAGR+196.2%
Studio
Year-over-Year Change

Total revenue from sales of goods and services

3Y CAGR
+197.4%/yr
Annual compound
5Y CAGR
+196.2%/yr
Consistent
Percentile
P93
Near historical high
vs 5Y Ago
228.2x
Strong expansion
Streak
1 yr
Consecutive declineContracting
PeriodValueYoY Change
TTM$38.79M-18.4%
2024$47.54M+123.7%
2023$21.25M+1341.6%
2022$1.47M-
2021$0.00-100.0%
2020$170000.00-
2019$0.00-
2018$0.00-
2017$0.00-
2016$0.00-